Stock exchange release

Free for publication on November 23, 2016 at 5 pm (CET+1)

Bittium Corporation changes its financial reporting practice and announces its financial calendar for the year 2017

Bittium Corporation will change its financial reporting practice as of January 1, 2017. The company will publish half year and annual financial reports and will no longer publish interim reports for the first three and nine months of the year. Bittium Corporation will publish its market outlook and financial outlook concerning the reporting period in its half year financial report and financial statement bulletin.

Bittium Corporation will release the following financial reports in 2017:

• Financial Statement Bulletin 2016: on February 20, 2017, at 8 am (CET+1)
• Half Year Financial Report January – June 2017: on August 9, 2017, at 8 am (CEST+1)

Bittium Corporation observes a three week silent period prior to announcing its financial reports. In 2017 the silent periods are as follows:

• January 30 - February 20, 2017
• July 19 - August 9, 2017

Bittium will release its annual report 2016 on March 21, 2017. The Annual General Meeting will be held on April 12, 2017 at 1 pm (CET+1) in Oulu, Finland.

Oulu, November 23, 2016
Bittium Corporation

Further information

Karoliina Fyrstén
Director, Corporate Communications and Marketing
Bittium Corporation
Tel. +358 40 344 2789

Distribution

NASDAQ Helsinki
Main media

Bittium

Bittium specializes in the development of reliable, secure communications and connectivity solutions leveraging its 30 year legacy of expertise in advanced radio communication technologies. Bittium provides innovative products and services, customized solutions based on its product platforms and R&D services. Complementing its communications and connectivity solutions, Bittium offers proven information security solutions for mobile devices and portable computers. Starting from November 10th, Bittium offers its customers also healthcare technology products and services in biosignal measuring in the areas of cardiology, neurology, rehabilitation, occupational health and sports medicine. Net sales of continuing operations in 2015 was EUR 56.8 million and operating profit was EUR 2.3 million. Bittium is listed on Nasdaq Helsinki. www.bittium.com

Files
Release (wkr0006.pdf)